ABSTRACTS
P18 EVALUATION OF THE TAV8® (STAGO) AGGREGOMETER IN THE CLINICAL LABORATORY
L. Schotte, K. Schatteman
P05 DIFFERENCES IN ACTIVITY OF PLASMA SPIKED WITH IDELVION® GENERATED WITH ONE-STAGE CLOTTING ASSAY USING DIFFERENT COMMERCIAL APTT REAGENTS COMPARED WITH CHROMOGENIC METHOD
I. Vangenechten, M. Maes, A. Gadisseur
P06 EVALUATION OF VON WILLEBRAND FACTOR MULTIMER DISTRIBUTION USING A NEW SEMI-AUTOMATED VON WILLEBRAND MULTIMERIC ASSAY, HYDRAGEL VW MULTIMER (SEBIA)
I. Vangenechten, A. Gadisseur
P07 EVALUATION OF AN AUTOMATED VON WILLEBRAND FACTOR COLLAGEN BINDING ASSAY, HEMOSIL® ACUSTAR® VWF:CB
I. Vangenechten, M. Maes, A. Gadisseur
P08 RESOLVING DOAC INTERFERENCE ON APTT, PT AND LUPUS ANTICOAGULANT TESTING BY THE USE OF ACTIVATED CARBON
G. Frans, E.j.a. Bailleul, P. Meeus
P09 COMPARISON OF THE EFFECT OF MANUAL SAMPLE TRANSPORT AND TWO DIFFERENT PNEUMATIC TRANSPORTATION SYSTEMS ON COAGULATION ASSAYS
P. De Kesel, K. Devreese
P10 METHOD VALIDATION OF THE NEW STAGO PT REAGENT STANEOPTIMAL FOR PT/INR MEASUREMENT
L. Florin, P. De Kesel, K. Devreese
P11 EFFECT OF UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN ON THE MEASUREMENT OF PT WITH TWO STAGO PT REAGENTS
L. Florin, P. De Kesel, K. Devreese
P12 SENSITIVITY OF THE NEW STAGO PT STA-NEOPTIMAL REAGENT FOR FACTOR DEFICIENCY ON STAGO STA-R EVOLUTION
L. Florin, P. De Kesel, K. Devreese
P13 THE VALUE OF LABORATORY SCREENING VS. CLINICAL JUDGMENT IN HIT DIAGNOSIS: EXPERIENCES IN THREE BELGIAN HOSPITALS
K. Eeckhout, G. Glynis, J. Emmerechts, K. Schatteman, M-B. Maes, E. Bailleul
P14 PRELIMINARY EVALUATION OF ADAMTS-13 ANTIBODY TESTING
N. Van Den Eede, J. Van Den Bossche, K. Deiteren, R. Malfait, M-B. Maes
P15 OPTIMISATION OF THE CALIBRATION CURVE FOR THE ACCURATE MEASUREMENT OF LOW FVIII LEVELS WITH ONE-STAGE ASSAYS
D.l.j. Van Den Bossche, J. Toelen, K. Peerlinck, M. Jacquemin
P16 HOW TO DEAL WITH SAMPLES WITH ERRORS ON APTT, PT AND FIBRINOGEN DUE TO OPTICAL CLOT DETECTION?
K. Eeckhout, J. Van Den Bossche, K. Deiteren, R. Malfait, M-B. Maes
P17 ESTABLISHMENT OF A THROMBIN GENERATION THRESHOLD IN SEVERE HAEMOPHILIAC PATIENTS UNDER PROPHYLAXIS TO FURTHER DETERMINE AN ADDED VALUE OF THIS TEST IN THE PERSONALIZED TREATMENT: A PILOT STUDY
L.r. Rozen, N. Moszynski, P.-Q. Le, P. Péters, A. Demulder
P04 DIFFERENCES IN FVIII MEASUREMENTS OF PLASMA SPIKED WITH AFSTYLA® GENERATED WITH ONE-STAGE CLOTTING ASSAY USING DIFFERENT COMMERCIAL APTT REAGENTS COMPARED WITH CHROMOGENIC METHOD
I. Vangenechten, M. Maes, A. Gadisseur
P19 EVALUATION OF AN AUTOMATED LIGHT TRANSMISSION AGGREGOMETRY
D. Gobin, C. Collard, I. Droushout, A. Demulder, B. Cantinieaux
P20 EVALUATION OF THE NEW KIT STA-VWF RCO (STAGO) MEASURING WILLEBRAND FACTOR ACTIVITY AND COMPARISON WITH TWO SIEMENS KITS: BC VON WILLEBRAND REAGENT AND INNOVANCE VW ACTIVITY
C.w. Goudji, I. Courtois, J. Yernaux, M. Blauwaert, D. Govaerts, P. Cauchie
P21 A NOVEL ADAMTS13 CONFORMATION ELISA SHOWS CONFORMATIONAL ACTIVATION OF RAT ADAMTS13 WITH EXPOSURE OF CRYPTIC EPITOPES IN VITRO
C. Dekimpe, L.c. VelÁsquez Pereira, J. Voorberg, H. Deckmyn, S.F. De Meyer, K. VanHoorelbeke
P22 ANTI-CUB1 OR ANTI-SPACER ANTIBODIES THAT INCREASE ADAMTS13 ACTIVITY ACT BY ALLOSTERICALLY ENHANCING METALLOPROTEASE DOMAIN FUNCTION
A.-S. Schelpe, A. Petri, N. VanDePutte, H. Deckmyn, S.F. De Meyer, J.t.b. Crawley, K. VanHoorelbeke
P23 BETRIXABAN: IMPACT ON ROUTINE AND SPECIFIC COAGULATION ASSAYS - A PRACTICAL LABORATORY GUIDE
R. Siriez, J. Evrard, J-M. Dogné, L. Pochet, F. Mullier, J. Douxfils
P24 IMPROVEMENT OF CHROMOGENIC ANTI-XA ASSAY TO MEASURE BETRIXABAN CONCENTRATION IN PLASMA
R. Siriez, J. Evrard, J-M. Dogné, L. Pochet, C. Bouvy, S. Lessire, F. Mullier, J. Douxfils
P25 CLOT WAVEFORM ANALYSIS: DETERMINATION OF OPTIMAL WAVELENGTH TO ASSESS THE FIBRIN COAGULATION PROCESS
J. Evrard, R. Siriez, L. Morimont, F. Mullier, J-M. Dogné, J. Douxfils
P26 ASSESSMENT OF INNER-FILTER OF THE REAGENTS OF THE COAGULATION PATHWAY ON BASELINE ABSORBANCE IN CLOT WAVEFORM ANALYSIS
J. Evrard, R. Siriez, L. Morimont, F. Mullier, J-M. Dogné, J. Douxfils
P27 VON WILLEBRAND FACTOR DEFICIENCY DOES NOT INFLUENCE ANGIOTENSIN I I-INDUCED ABDOMINAL AORTIC ANEURYSM FORMATION IN MICE
I. Portier, K. Martinod, L. Desender, N. VanDePutte, H. Deckmyn, K. VanHoorelbeke, S.F. De Meyer
P28 THE MECHANISM OF THE LOSS OF HMW VWF MULTIMERS AFTER LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION IS DIFFERENT BETWEEN HUMANS AND SHEEP
S. Deconinck, A.-S. Schelpe, S. Jacobs, C. Nix, S. Barth, H.B. Feys, N. VanDePutte, C. Tersteeg, H. Deckmyn, S.F. De Meyer, B. Meyns, K. VanHoorelbeke
P29 WHY DO SOME GRAFTS, USED IN RVOT (RIGHT VENTRICULAR OUTFLOW TRACT) REVALVULATION, GET INFECTED AND OTHERS DO NOT?
B. Ditkowski, M. Bezulskaditkowska, R. Veloso, R. Jashari, M. Gewillig, M. Hoylaerts, B. Meyns, R. Heying
P30 VWF DEFICIENCY IS ASSOCIATED WITH RETICULOCYTOSIS AND INCREASED PARASITE ACCUMULATION IN EXPERIMENTAL MALARIA-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME
S. Kraisin, S. Verhenne, T.-T. Pham, K. Martinod, I. Portier, N. VanDePutte, H. Deckmyn, K. VanHoorelbeke, P.E. Van Den Steen, S.F. De Meyer
O01 INHERITED ANTITHROMBIN DEFICIENCY AND THROMBOSIS IN CHILDHOOD: DATA FROM A LARGE MULTICENTRIC COHORT
C. Orlando, B. De La Morena-barrio, M.e. De La Morena-barrio, V. Vicente, J. Corral, K. Jochmans
Should we measure DOACs?
J. Beekwilder, T. Feys
The new mechanism of autoimmunity is a HIT
J. Beekwilder, T. Feys
SHOULD WE MEASURE DOACS?
J. Douxfils
ANTI-PF4/POLYANION ANTIBODY INDUCED AUTOIMMUNE HIT: A NEW MECHANISM OF AUTOIMMUNITY
A. Greinacher
MECHANISMS AND RISK FACTORS OF THROMBOSIS IN CANCER
A. Falanga
CANCER-ASSOCIATED THROMBOSIS: HOW TO PREVENT, HOW TO TREAT?
C. Ay
APPROACH TO THROMBOSIS IN UNUSUAL SITES: SVT AND CVT
W. Ageno
STAPHYLOCOCCUS AUREUS: MASTER MANIPULATOR OF THE HUMAN HEMOSTATIC SYSTEM
T. Vanassche
CARDIAC DEVICE INFECTION: INCIDENCE, DIAGNOSIS AND TREATMENT
L. Musumeci, C. Oury, P. Lancellotti
MICROBIOTA AND THROMBOSIS
C. Reinhardt
O02 PLATELET-RICH BUT NOT RBC-RICH AREAS IN STROKE THROMBI CONSIST OF DENSE FIBRIN STRUCTURES, VWF AND EXTRACELLULAR DNA
S. Staessens, F. Denorme, O. François, L. Desender, T. Dewaele, P. Vanacker, H. Deckmyn, K. VanHoorelbeke, T. Andersson, S.F. De Meyer
O03 LUPUS ANTICOAGULANT HYPOPROTHROMBINAEMIA SYNDROME: A PAEDIATRIC CASE REPORT
S. Vandamme, K. Ver Elst, M-B. Maes, S. Vermeiren
O04 THE PRESENCE OF ANTI-ADAMTS13 AUTO-ANTIBODIES DOES NOT CHANGE ADAMTS13 ANTIGEN LEVELS MEASURED BY AN IN HOUSE DEVELOPED ADAMTS13 ANTIGEN ELISA
C. Dekimpe, C. Tersteeg, E. Roose, C. Vendramin, N. VanDePutte, I. Pareyn, A. Vandenbulcke, H. Deckmyn, M. Scully, E. Tellier, S.F. De Meyer, K. VanHoorelbeke
O05 THE CONCENTRATION OF GP1BA MAGNETIC PARTICLES IS A CRITICAL PARAMETER OCCASIONALLY RESPONSIBLE FOR POOR REPRODUCIBILITY OF THE VWF:RCO WITH A CHEMILUMINESCENT IMMUNOASSAY
B. Calcoen, I. Van Horenbeeck, M. Debasse, J. Toelen, I. Vanlinthout, J. Schoeters, K. Peerlinck, M. Jacquemin
O06 OPEN ADAMTS13 CONFORMATION IN IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA IS INDUCED BY ANTI-ADAMTS13 AUTOANTIBODIES
E. Roose, A.-S. Schelpe, E. Tellier, G. Sinkovits, G. Kaplanski, M. Le Besnerais, I. Mancini, H.B. Feys, N. VanDePutte, A. Vandenbulcke, I. Pareyn, J. Voorberg, A. Greinacher, Y. Benhamou, H. Deckmyn, R. Fijnheer, Z. ProhÁszka, F. Peyvandi, P. Coppo, S.F. De Meyer, A. Veyradier, K. VanHoorelbeke
O07 THE VWF-GPIB INTERACTION MEDIATES THROMBO-INFLAMMATION IN EXPERIMENTAL STROKE VIA RECRUITMENT OF MONOCYTES, NEUTROPHILS AND T-CELLS TO THE BRAIN
F. Denorme, K. Martinod, A. Vandenbulcke, C.v. Denis, P.j. Lenting, H. Deckmyn, K. VanHoorelbeke, S.F. De Meyer
O08 THE DIFFERENTIAL ROLE OF PLATELETS AND FIBRIN IN ADHESION ON INFLAMED AND DAMAGED VALVES IN A NEW MOUSE MODEL OF EARLY STAPHYLOCOCCUS AUREUS ENDOCARDITIS
O09 VISUALIZING DENSE GRANULE FORMATION IN MEGAKARYOCYTES USING ADVANCED MICROSCOPY AND ITS APPLICATION FOR HERMANSKY-PUDLAK SYNDROME
J. Heremans, C. Thys, K. Cludts, V. Labarque, C. Van Geet, K. Freson
O10 P2X1 DEFICIENCY CAUSES MASSIVE INTESTINAL BLEEDING ALONG WITH ENHANCED NEUTROPHIL-DEPENDENT THROMBOSIS IN COLITIS
O. Wéra, L. Servais, C. Delierneux, A. Hego, C. Lecut, A. Keutgens, P. Delvenne, A. Nchimi, P. Lancellotti, C. Oury
P01 EVALUATION OF THE COBAS T 711 COAGULATION ANALYSER: A SINGLE CENTER EXPERIENCE
C. Orlando, S. Damiaens, Ö. Belce, K. Jochmans
P02 A CHALLENGING CASE OF ACQUIRED HAEMOPHILIA MANIFESTING AS HAEMATURIA
C. Lecut, M. Joiret, A. Gothot, P. Péters
P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY
I. Vangenechten, J. Jongenotter, K. Jochmans, C. Orlando, A. Gothot, K. Vandenbosch, A. Gadisseur
Top
